Stock listing
Kontafarma China Holdings Ltd
Selected listing: 1312 · HKEX · HKD · HK
Kontafarma China Holdings Ltd (HKEX:1312), Non-Energy Minerals. Latest release May 8, 2026: Kontafarma China Appoints Wang Limin As Executive Director…
- Ticker
- HKEX:1312
- Asset type
- Stock
- Sector
- Non-Energy Minerals
- Industry
- Construction Materials
- Exchange
- HKEX
- Currency
- HKD
About Kontafarma China Holdings Ltd
The company operates in the pharmaceutical sector, focusing on the development and distribution of healthcare products. Its strategic initiatives aim to enhance its presence in the Chinese market.
Latest news from Kontafarma China Holdings Ltd
Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
May 8, 2026
Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr
April 16, 2026
Kontafarma China Posts Loss For Year Attributable HKD 427.8 Million
March 27, 2026
Kontafarma China Expects FY2025 Consolidated Net Loss Of HK$414.1 Million-HK$506.2 Million
March 11, 2026
Kontafarma China Says Qiao Linna Resigns As Executive Director, Vice President
November 14, 2025
Research Kontafarma China Holdings Ltd
Kontafarma China Holdings Ltd company profile
View the public company page for Kontafarma China Holdings Ltd on 6ix.
Kontafarma China Holdings Ltd news
Read company news and market updates connected to Kontafarma China Holdings Ltd.
Kontafarma China Holdings Ltd investor events
Find investor webinars, events, and replay context for Kontafarma China Holdings Ltd.